NASDAQ:BLKB
Blackbaud Stock News
$78.03
-0.400 (-0.510%)
At Close: May 03, 2024
Bestselling Author and Activist Glennon Doyle to Join the Mainstage at Blackbaud's bbcon 2022 Virtual Conference
10:05am, Wednesday, 17'th Aug 2022
The Tech Conference for Good Will Take Place Oct. 17–18 as a Free, Virtual Event CHARLESTON, S.C. , Aug. 17, 2022 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading cloud software com
Blackbaud (BLKB) Surpasses Q2 Earnings Estimates
08:21pm, Tuesday, 02'nd Aug 2022
Blackbaud (BLKB) delivered earnings and revenue surprises of 8.70% and 0.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Blackbaud Announces Date of Second Quarter 2022 Financial Results
04:10pm, Tuesday, 12'th Jul 2022
CHARLESTON, S.C. , July 12, 2022 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading cloud software company powering social good, will report its second quarter 2022 financial results on
Here's Why Blackbaud (BLKB) Warrants a Bullish Stance Now
01:27pm, Tuesday, 21'st Jun 2022
Blackbaud (BLKB) is well-poised to gain from accelerated cloud migration by enterprises taking place globally
Blackbaud (BLKB) Adds Prospect Insights to Raiser's Edge NXT
01:51pm, Monday, 06'th Jun 2022 Zacks Investment Research
Blackbaud (BLKB) announces the launch of Prospect Insights to offer multi-dimensional fundraising insights and actions.
Why Is Blackbaud (BLKB) Up 12.5% Since Last Earnings Report?
03:31pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
Blackbaud (BLKB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
‘Social good' cloud provider Blackbaud takes millions from the NRA
01:47pm, Thursday, 02'nd Jun 2022
Blackbaud, which bills itself as the “leading cloud software company powering social good,” counts the National Rifle Association as a customer receiving its highest level of care and engagement,
Can Blackbaud (BLKB) Climb 37% to Reach the Level Wall Street Analysts Expect?
01:55pm, Tuesday, 17'th May 2022 Zacks Investment Research
The consensus price target hints at a 37.1% upside potential for Blackbaud (BLKB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat
Blackbaud (BLKB) Q1 Earnings Miss Estimates, Revenues Up Y/Y
03:01pm, Wednesday, 04'th May 2022 Zacks Investment Research
Blackbaud's (BLKB) first-quarter 2022 revenues benefit from increased recurring revenues and higher transactional volume.
Blackbaud, Inc. (BLKB) CEO Mike Gianoni on Q1 2022 Results - Earnings Call Transcript
01:25pm, Wednesday, 04'th May 2022
Blackbaud, Inc. (NASDAQ:BLKB ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Steve Hufford - Director, Investor Relations Mike Gianoni - President and CEO Tony Boor - Ex
Blackbaud (BLKB) Q1 Earnings Miss Estimates
10:35pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Blackbaud (BLKB) delivered earnings and revenue surprises of -12.31% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Blackbaud (BLKB) Q1 Earnings Miss Estimates
08:19pm, Tuesday, 03'rd May 2022
Blackbaud (BLKB) delivered earnings and revenue surprises of -12.31% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Manhattan Associates (MANH) Beats Q1 Earnings and Revenue Estimates
09:45pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Manhattan Associates (MANH) delivered earnings and revenue surprises of 33.33% and 6.01%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Blackbaud Announces Date of First Quarter 2022 Financial Results
04:10pm, Tuesday, 19'th Apr 2022
CHARLESTON, S.C. , April 19, 2022 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading cloud software company powering social good, will report its first quarter 2022 financial results
Zacks.com featured highlights Ligand Pharmaceuticals, Las Vegas Sands, CoStar Group and Blackbaud
10:26am, Friday, 01'st Apr 2022 Zacks Investment Research
Ligand Pharmaceuticals, Las Vegas Sands, CoStar Group and Blackbaud have been highlighted in this Screen of the Week article.